Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Operating Expenses | 3,148 | 3,530 | 3,258 | 3,304 | 2,494 |
| Operating Income | -3,148 | -3,530 | -3,258 | -3,304 | -2,494 |
| Other Income | 870 | 634 | 531 | 98 | 55 |
| Pre-tax Income | -2,278 | -2,897 | -2,727 | -3,206 | -2,440 |
| Income Tax | 110 | 127 | 38 | 28 | 27 |
| Net Income Continuous | -2,388 | -3,024 | -2,765 | -3,234 | -2,467 |
| Net Income | $-2,388 | $-3,024 | $-2,765 | $-3,234 | $-2,467 |
| EPS Basic Total Ops | -0.12 | -0.02 | -0.17 | -0.40 | -0.30 |
| EPS Basic Continuous Ops | -0.12 | -0.01 | -0.17 | -0.40 | -0.30 |
| EPS Diluted Total Ops | -0.12 | -0.02 | -0.17 | -0.40 | -0.30 |
| EPS Diluted Continuous Ops | -0.12 | -0.01 | -0.17 | -0.40 | -0.30 |
| EBITDA(a) | $-3,133 | $-3,494 | $-3,263 | $-3,295 | $-2,487 |